Web-based study on Chinese dermatologists’ attitudes towards artificial intelligence
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Artificial intelligence (AI) has become a powerful tool and is attracting more attention in the field of medicine. There are a number of AI studies focusing on skin diseases, and there are many AI products that have been applied in dermatology. However, the attitudes of dermatologists, specifically those from China, towards AI, is not clear as few, if any studies have focused on this issue. METHODS: A web-based questionnaire was designed by experts from the Chinese Skin Image Database (CSID) and published on the UMER Doctor platform (an online learning platform for dermatologists developed by the Shanghai Wheat Color Intelligent Technology Company, China). A total of 1,228 Chinese dermatologists were recruited and provided answers to the questionnaire online. The differences of dermatologists' attitudes towards AI among the different groups (stratified by age, gender, hospital level, education degree, professional title, and hospital ownership) were compared by using the Mann-Whitney U test and the Kruskal-Wallis H test. The correlations between stratified factors and dermatologists' attitudes towards AI were calculated by using the Spearman's rank correlation test. SPSS (version 22.0) was utilized for all analyses. A two-sided P value <0.05 was considered statistically significant in all analyses. RESULTS: A total of 1,228 Chinese dermatologists from 30 provinces, autonomous regions, municipalities, and other regions (including Hong Kong, Macau, and Taiwan) participated in this survey. The dermatologists who participated acquired AI-related information mainly through the Internet, meetings or forums, and 70.51% of participated dermatologists acquired AI-related information by two or more approaches. In total, 99.51% of participated dermatologists pay attention (general, passive-active, and active attention) to information pertaining to AI. Stratified analyses revealed statistically significant differences in their attention levels (unconcerned, general, passive-active, and active attention) to AI-related information by gender, hospital level, education degree, and professional title (P values ≤1.79E-02). In total, 95.36% of the participated dermatologists thought the role of AI to be in "assisting the daily diagnosis and treatment activities for dermatologists". Stratified analyses about the thought of AI roles (unconcerned, useless, assist, and replace) showed that there was no statistically significant difference except for the hospital level (P value =4.09E-03). The correlations between stratified factors with attention levels and the opinions of AI roles showed extremely weak correlations. Furthermore, 64.17% of participated dermatologists thought secondary hospitals in China are in most need of the application AI, and 91.78% of participated dermatologists thought the priority implementation of AI should be in skin tumors. CONCLUSIONS: The majority of Chinese dermatologists are interested in AI information and acquired information about AI through a variety of approaches. Nearly all dermatologists are attentive to information on AI and think the role of AI is in "assisting the daily diagnosis and treatment activities for dermatologists". Future AI implementation should be primarily focused on skin tumors and utilized in in secondary hospitals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nadarzynski, T., Miles, O., Cowie, A., & Ridge, D. (2019) · DIGITAL HEALTH · doi:10.1177/2055207619871808 · Cited by 810 · cited 1×
“pdf) by reviewing the literatures (20-24) and consulting the CSID expert committee.”
MethodMedical students' attitude towards artificial intelligence: a multicentre survey
Pinto dos Santos, D., Giese, D., Brodehl, S., Chon, S. H., Staab, W., Kleinert, R., Maintz, D., & Baeßler, B. (2019) · European Radiology · doi:10.1007/s00330-018-5601-1 · Cited by 754 · cited 2×
“In a multicenter survey, around 52% of medical students were aware of the ongoing discussion about AI in radiology; however, 68% of them stated that they were unaware of the specific technologies involved (23).”
BackgroundMethodBrinker, T. J., Hekler, A., Enk, A. H., Klode, J., Hauschild, A., Berking, C., Schilling, B., Haferkamp, S., Schadendorf, D., Holland-Letz, T., et al. (2019) · European Journal of Cancer · doi:10.1016/j.ejca.2019.04.001 · Cited by 605 · cited 1×
“Thus far, many well-known and meaningful AI studies have been conducted which have focused on the recognition and classification of skin diseases, including skin cancers (5-13), atopic dermatitis (14), psoriasis (15,16), and onychomycosis (17).”
BackgroundTschandl, P., Codella, N., Akay, B. N., Argenziano, G., Braun, R. P., Cabo, H., Gutman, D., Halpern, A., Helba, B., Hofmann-Wellenhof, R., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30333-x · Cited by 555 · cited 3×
“Although AI has reached a performance above their human counterparts in many aspects, the higher diagnostic accuracy with digital images does not necessarily translate into better clinical performance or patient management (20).”
BackgroundMethodHan, S. S., Park, G. H., Lim, W., Kim, M. S., Na, J. I., Park, I., & Chang, S. E. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191493 · Cited by 305
Pathologist-level classification of histopathological melanoma images with deep neural networks
Hekler, A., Utikal, J. S., Enk, A. H., Berking, C., Klode, J., Schadendorf, D., Jansen, P., Franklin, C., Holland-Letz, T., Krahl, D., et al. (2019) · European Journal of Cancer · doi:10.1016/j.ejca.2019.04.021 · Cited by 231
Brinker, T. J., Hekler, A., Hauschild, A., Berking, C., Schilling, B., Enk, A. H., Haferkamp, S., Karoglan, A., von Kalle, C., Weichenthal, M., et al. (2019) · European Journal of Cancer · doi:10.1016/j.ejca.2018.12.016 · Cited by 157 · cited 1×
“Thus far, many well-known and meaningful AI studies have been conducted which have focused on the recognition and classification of skin diseases, including skin cancers (5-13), atopic dermatitis (14), psoriasis (15,16), and onychomycosis (17).”
BackgroundSmartphone applications for triaging adults with skin lesions that are suspicious for melanoma
Chuchu, N., Takwoingi, Y., Dinnes, J., Matin, R. N., Bassett, O., Moreau, J. F., Bayliss, S. E., Davenport, C., Godfrey, K., O'Connell, S., et al. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013192 · Cited by 144 · cited 1×
“Thus far, many well-known and meaningful AI studies have been conducted which have focused on the recognition and classification of skin diseases, including skin cancers (5-13), atopic dermatitis (14), psoriasis (15,16), and onychomycosis (17).”
BackgroundCabitza, F., & Zeitoun, J.-D. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.04.07 · Cited by 72 · cited 1×
“Currently, AI is widely used in many fields, including in medical areas and healthcare systems (1-3).”
Background
Cited by
Chen, M., Zhang, B., Cai, Z., Seery, S., Gonzalez, M. J., Ali, N. M., Ren, R., Qiao, Y., Xue, P., & Jiang, Y. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.990604 · Cited by 258
(2023) · doi:10.2196/40337 · Cited by 156
Melarkode, N., Srinivasan, K., Qaisar, S. M., & Plawiak, P. (2023) · Cancers · doi:10.3390/cancers15041183 · Cited by 144
A healthy debate: Exploring the views of medical doctors on the ethics of artificial intelligence
Martinho, A., Kroesen, M., & Chorus, C. (2021) · Artificial Intelligence in Medicine · doi:10.1016/j.artmed.2021.102190 · Cited by 124
Ghotbi, N., Ho, M. T., & Mantello, P. (2022) · AI & SOCIETY · doi:10.1007/s00146-021-01168-2 · Cited by 99
Metadata
- Authors
- Shen, C., Li, C., Xu, F., Wang, Z., Shen, X., Gao, J., Ko, R., Jing, Y., Tang, X., Yu, R., Guo, J., Xu, F., Meng, R., & Cui, Y.
- Venue
- Annals of Translational Medicine
- Publisher
- AME Publishing Company
- Published
- 2020-06
- Volume
- 8
- Issue
- 11
- Pages
- 698-698
- ISSN
- 2305-5839 (ISSN-L)
- 2305-5847
- OpenAlex
- W2997928374
- Cited by
- 29
- References
- 9
- FWCI
- 1.07
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.